Search Within
Document Type
259-145-5
Applied Filters:
Keyword:'259-145-5'
Showing 1-30 of 37 results for "259-145-5" within Technical Documents
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
In Vitro Toxicology Kits
Necrosis Factor Using WEHI 164 Cells Cultured on Novel Microtiter
Plates. J. Immunol. Methods, 145: 259-262.
16. Knox, P. et al. (1986). The FRAME Multicentre Project on In Vitro Toxicology. Foundations
Data Sheet - 06564
636 (1989).
5. Seeger, D.R. et al., J. Amer. Chem. Soc.,
71, 1753 (1949).
6. Sigma Biosciences, Cell Culture Division.
7. Horenstein, A.L. et al., J. Immunological
Methods, 98, 145-149 (1987).
Data Sheet - 06563
p. 636 (1989).
5. Seeger, D.R. et al., J. Amer. Chem. Soc., 71, 1753 (1949).
6. Sigma Biosciences, Cell Culture Division.
7. Horenstein, A.L. et al., J. Immunological Methods, 98, 145-149 (1987).
8.
Product Information Sheet - TOX4
:173-179.
5. Morgan, C. et al. [1991] An improved colorimetric
assay for tumor necrosis factor using WEHI 164
cells cultured on novel microtiter plates. J.
Immunol. Methods 145:259-262.
XP725 Antibody Number-Lot Number 071M4826
207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216 237 238 239 240 261 262
Product Information Sheet - R3501
, 17, 529, 1967.
10. Wehrli, W., Rev. of Infect. Dis., 5, Supplement 3, S407, July-August 1983.
11. Hartmann, G. et al., Biochim. Biophys. Acta 145, 843, 1967.
12. Lester, W., Annu. Rev. of Microbiol.
LABORATORY NOTEBOOK ISSUANCE PAGE
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3)
Oxygen O 8 [15.999 03; 15.999 77]
Palladium Pd 46 106.42(1)
Phosphorus P 15
LABORATORY NOTEBOOK ISSUANCE PAGE
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3)
Oxygen O 8 [15.999 03; 15.999 77]
Palladium Pd 46 106.42(1)
Phosphorus P 15
LABORATORY NOTEBOOK ISSUANCE PAGE
Nickel Ni 28 58.6934(4)
Niobium Nb 41 92.906 38(2)
Nitrogen N 7 [14.006 43; 14.007 28]
Nobelium No 102 [259]
Osmium Os 76 190.23(3)
Oxygen O 8 [15.999 03; 15.999 77]
Palladium Pd 46 106.42(1)
Phosphorus P 15
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
114 2 198 4 247 5
IPI00479708 IGHM protein 131 3 87 3
IPI00419424 IGKV1-5 protein 154 2 183 2 171 3 147 2
IPI00719373 IGLC1 protein 202 3
IPI00719452 IGLC1 protein 99 2 81 1
PAI Activity Assay Kit
200
20 10 130 20 20 200
10 10 140 20 20 200
5 10 145 20 20 200
2.5 10 147.5 20 20 200
1.25 10 148.75 20 20 200
0.0 10 150 20 20 200
Product Information Sheet - CS0230
Leukot. Essent. Fatty Acids., 69,
145-155 (2003).
6
8. Wennergreen, G., Inflammatory mediators in blood
and urine. Paediatr. Respir. Rev., 3, 259-265
(2000).
9. Severien C., Urinary
An Update on Ligands for Prostanoid Receptors
EP4
receptors in some tissues. AH 13205 is a selective, but low-
potency, EP2 agonist [43]. ONO-AE1-259 is increasingly
being used in preference to butaprost as it is more potent,
although it does possess
Integration of Experimental and Computational Microfluidics in 3D Tissue Engineering
Mechano-Biology, V. C. Mow and R. Huiskes, (eds.), Philadelphia, PA: Lippincott
Williams & Wilkins, 2005, pp. 259–300.
[3] Williams, K. A., S. Saini, and T. M. Wick, “Computational Fluid Dynamics Modeling of Steady-State
Protein Sample Preparation Tools for Signal Transduction Research & Proteomics
M.L. 2005. Truncated E-cadherin potentiates cell
death in prostate epithelial cells. Prostate 63, 259.
Chang, T.S., et al. 2004. Peroxiredoxin III, a mitochondrion-specific peroxi-
dase, regulates apoptotic
Calbiochem Biologics 29.2
Cat. No. 526612 5 µg
Ref.: Barillari, G., et al. 1998. Am. J. Pathol. 152, 1161; Ziche, M. et al. 1997.
Lab Invest. 76, 517; Hauser, S., and Weich, H.A. 1993. Growth Factors 9, 259.
TSRI265
A potent
List of Antibodies
Estrogen Receptor E0521 P y n/d n/d
257 Estrogen Receptor E1396 P y n/d n/d
258 Exportin T E1531 M y y y
259 Ezrin E8897 M y y y
260 F1A F3428 P y y y
261 FADD F8053 M y n/d n/d
262 Focal
Evaluation of Intracellular Signaling - Downstream Chimeric Antigen Receptors
trapped in the periphery and benefit from combined CD28-OX40 costimula-
tion. HumGene Ther. 2013; 24(3):259–69. Epub 2013/01/29. doi: 10.1089/hum.2012.247 PMID:
23350854.
40. Pule MA, Savoldo B, Myers GD
Cytoskeletal Signaling Antibodies, Reagents and Kits
µg MAB3240
Po Ca Fe
Catenin
Polyclonal Antibody
Anti-d-Catenin M R WB Pur Rb IgG 100 µg 07-259
Caveolin
Monoclonal Antibody
Anti-Caveolin-1 7C8 H R WB IP IC Pur M IgG2b 200 µg 05-762
Polyclonal
XP725 Antibody List Lot 089K4791
7414 VCL M NP_003364.1 ,NP_054706.1 y y n/d
753 VDAC/Porin V2139 7416 VDAC1 P NP_003365.1 , y y y
259 Ezrin E8897 7430 EZR M NP_001104547.1 y y n/d
758 Vimentin V6389 7431 VIM M NP_003371.2 y n/d y
752
XP725 Antibody List Lot 129K4831
7414 VCL M NP_003364.1 ,NP_054706.1 y y n/d
753 VDAC/Porin V2139 7416 VDAC1 P NP_003365.1 , y y y
259 Ezrin E8897 7430 EZR M NP_001104547.1 y y n/d
758 Vimentin V6389 7431 VIM M NP_003371.2 y n/d y
752
XP725 Antibody List Lot 129K4830
7414 VCL M NP_003364.1 ,NP_054706.1 y y n/d
753 VDAC/Porin V2139 7416 VDAC1 P NP_003365.1 , y y y
259 Ezrin E8897 7430 EZR M NP_001104547.1 y y n/d
758 Vimentin V6389 7431 VIM M NP_003371.2 y n/d y
752
Inhibitor Sourcebook 3rd Edition
. Rev. 84, 137.
Taylor, S.S., et al. 2004. Biochim. Biophys. Acta 1697, 259.
Skålhegg, B.S., and Tasken, K. 2000. Front. Biosci. 5, 678.
Spaulding, S.W. 1993. Endocrine Rev. 14, 632.
AGC kINASe INhIBITORS
XP725 Worksheet for Lot Number 071M4826
139 1 3 6 3 BID B3183
140 1 3 6 4 BID B3183
141 1 3 6 5 Bim B7929
142 1 3 6 6 Bim B7929
Anti CY3/5 C0992143 1 3 6 7
144 1 3 6 8 Anti CY3/5 C0992
145
Page 1 of 2